Elon Musk's Neuralink Corp. has finally disclosed the identity of the first brain implant patient, that too, in a live streaming video on X, formerly Twitter.
What Happened: On Wednesday, Musk shared a video on X, a live-streaming session by Neuralik, which showed Noland Arbaugh, 29, playing Chess. “Livestream of @Neuralink demonstrating ‘Telepathy’ – controlling a computer and playing video games just by thinking.”
While introducing himself, Arbaugh said, "About eight years ago I was in kind of a freak diving accident and dislocated my C4, C5. So, I am a complete quadriplegic. So, I am paralyzed below the shoulders. I have no level of movement below my injuries, below my shoulders."
The camera then panned to a laptop screen, kept in front of Arbaugh with a Chess game on.
"I love playing Chess. So, this is one of the things you'll have enabled me to do," the first Neuralink patient said, who was accompanied by an engineer at Neuralink.
He then showed himself using the cursor on the screen with the help of the Neuralink device. "I wasn't able to really do much the last few years, especially not like this. I have used like a mouse stick and stuff, but now it's all being done with my brain."
Why It's Important: Earlier this month, it was reported that the first Neuralink patient had fully recovered, but concerns about his long-term health were raised.
The N1 brain implant from Neuralink, designed to be cosmetically invisible, captures and wirelessly transmits brain signals to an application that interprets movement intentions.
Ark Investment analyst Pierce Jamieson previously predicted that by 2030, this technology could generate revenue exceeding $220 million from ALS patients.
However, regulatory concerns have been raised regarding the safety protocols and transportation of hazardous materials associated with Musk's company.
Check out more of Benzinga’s Consumer Tech coverage by following this link.
Read Next: Neuralink-Inspired Token Soars 3400% After Elon Musk Announces First Human Implant
Photo via Wikimedia Commons
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
